MHRA Threat to clinics In communication with the MHRA, they also stated: However, we do have concerns about the level of clinical oversight present in IV vitamin therapy and injection services in general and the appropriacy of such services is currently under review. This review, if deciding on stopping treatment of B12 injections by clinics who do comply with the ridiculous rules of the MHRA, would not only negatively impact the companies and individuals who give B12 injections, but also to the people who rely on them to keep functioning both physically and mentally
Try saying t" Questions people ask Frequently asked questions What is 5-Amino-1MQ best for
+ Match the vial lot to the report and confirm the counterion, formula, molecular-weight basis, HPLC purity, mass-spectrometry assignment, test date, sample amount, and finished-lot traceability
Different clinics may use different amounts of each ingredient
This means every 0.1ml (10 units on a standard insulin syringe) contains 250mcg of AOD-9604